Neuraxis (AMEX:NRXS) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.21) by 20.93 percent. This is a 26.09 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $968.127 thousand which beat the analyst consensus estimate of $850.000 thousand by 13.90 percent. This is a 27.19 percent increase over sales of $761.165 thousand the same period last year.